Trial Profile
PPL GLAU 13: A Randomized Phase 2 Study of the Effect of Plug Placement on Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jun 2014
Price :
$35
*
At a glance
- Drugs Latanoprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Mati Therapeutics; Novelion Therapeutics
- 11 Jun 2014 New trial record